CLINICAL_TRIALS
trial_result
· 2021-04-05
Clinical Trial Update: Thymosin Alpha 1 in the Prevention of Pancreatic Infection Following Acute Necrotizing Pancreatitis [Phase 4]
Summary
Phase 4 trial updating thymosin alpha-1 for prevention of pancreatic infection after acute necrotizing pancreatitis has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Weiqin Li | Conditions: Pancreatitis, Acute Necrotizing | Phase 4 | Status: COMPLETED